The purpose of this requirement is to develop and test two variations of a non-electric, disposable, pre-filled intravenous (IV) infusion pump. The purpose of this modification is to remove the…

Ended Purchase Order Awarded Last action

Contract number
W81XWH13P0483
Awardee
Awarding agency
Obligated
$3,972,717

Award facts

Contract value 100% obligated
$3,972,716.51 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Not Competed · 1 offer Only One Source
Pricing
Firm Fixed Price
Place of performance
San Francisco, CA 94107, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00018 $0
Supplemental Agreement for work within scope P00017 · The purpose of this requirement is to obtain FDA approval for the bioq pharma medical device. The purpose of this modification is to extend the period of… $0
Supplemental Agreement for work within scope P00016 · Modification to extend the period of performance for clins 2001, 2003, and 3002 until 31 december 2019. $0
Other Administrative Action P00015 · The purpose of this modification is to change the dodaac in the wawf clause and delivery addresses for clins 2001, 2003, and 3002 to transfer the contract to… $0
Funding Only Action P00014 · DE-obligating excess funds. Other direct costs, base year -$1
Other Administrative Action P00013 $0
Change Order P00010 $0
Supplemental Agreement for work within scope P00009 $1,272,726
Vendor DUNS or Name Change - Non-Novation P00008 $0
Other Administrative Action P00007 $0
Exercise an Option P00006 $0
Other Administrative Action P00005 $0
Exercise an Option P00004 $1,040,920
Other Administrative Action P00003 $0
Change Order P00002 $0
Other Administrative Action P00001 · Other direct costs, base year $0
Original award $1,659,072
Show all 17

About this award

Written by GovTribe AI ·

This is a firm-fixed-price purchase order contract awarded by the U.S. Army Medical Command (MEDCOM) to Bioq Pharma Incorporated, a subsidiary of West Pharmaceutical Services, Inc. The contract has a ceiling value of $3,972,716.51 and a completion date of January 15, 2021. The contract was awarded on September 27, 2013 and is not set-aside. Based on the agency and nature of the work, this contract is likely for the development, testing, or procurement of medical products or technologies for the U.S. Army's healthcare operations. No additional details about the specific products or services being provided were included in the information provided.

Description

As the agency reported it.

The purpose of this requirement is to develop and test two variations of a non-electric, disposable, pre-filled intravenous (IV) infusion pump. The purpose of this modification is to remove the requirement for the contractor to obtain FDA approval.

Quick answers

Who was awarded contract W81XWH13P0483?

W81XWH13P0483 was awarded to Bioq Pharma Incorporated by Medical Command (Department of the Army) on September 27, 2013.

How much is contract W81XWH13P0483 worth?

The government has obligated $3,972,717 on W81XWH13P0483.

Was contract W81XWH13P0483 competed?

The extent of competition for W81XWH13P0483 was not competed. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login